A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models
Author:
Funder
BioCanRx Clinical, Social and Economic Impact Program
Ottawa Hospital
Publisher
Elsevier BV
Subject
Hematology
Reference84 articles.
1. Virchow’s contribution to the understanding of thrombosis and cellular biology;Kumar;Clin Med Res.,2010
2. Venous thromboembolism and cancer: risks and outcomes;Lee;Circulation,2003
3. Managing thrombosis in cancer patients;Wang;Research and Practice in Thrombosis and Haemostasis,2018
4. Cancer-associated thrombosis: the when, how and why;Fernandes;European Respiratory Review: an official journal of the European Respiratory Society,2019
5. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;The New England Journal of Medicine,2003
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Preventative and curative treatment of venous thromboembolic disease in cancer patients;La Presse Médicale;2024-09
2. Heparin: An old drug for new clinical applications;Carbohydrate Polymers;2022-11
3. Not Just Anticoagulation—New and Old Applications of Heparin;Molecules;2022-10-17
4. An in vivo rabbit joint injury model to measure trauma-induced coagulopathy and the effect of timing of administration of ketotifen fumarate on posttraumatic joint contracture;OTA International: The Open Access Journal of Orthopaedic Trauma;2022-03
5. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles;Cells;2021-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3